These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 748672)

  • 1. Antibody responses to influenza vaccination in patients with chronic renal failure.
    Osanloo EO; Berlin BS; Popli S; Ing TS; Cummings JE; Gandhi VC; Geis WP; Hano JE
    Kidney Int; 1978 Dec; 14(6):614-8. PubMed ID: 748672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccination in patients with chronic renal failure.
    Nikoskelainen J; Väänänen P; Forsström J; Kasanen A
    Scand J Infect Dis; 1982; 14(4):245-51. PubMed ID: 7163777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequate seroresponse to influenza vaccination in dialysis patients.
    Antonen JA; Hannula PM; Pyhälä R; Saha HH; Ala-Houhala IO; Pasternack AI
    Nephron; 2000 Sep; 86(1):56-61. PubMed ID: 10971154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C; Sayan M; Sifil A; Artuk C; Yilmaz N; Bahar H; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):71-6. PubMed ID: 12745749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to influenza vaccine in hemodialysis patients with chronic renal failure.
    Mastalerz-Migas A; Steciwko A; Brydak LB
    Adv Exp Med Biol; 2013; 756():285-90. PubMed ID: 22836646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
    Boucher DW; Contreras G; Furesz J
    Can Med Assoc J; 1979 Apr; 120(7):799-802, 831. PubMed ID: 427686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune response to influenza vaccination among peritoneal dialysis patients].
    Dogliani M; Fidelio T; Scalzo B; Iacono G; Bagatella M; Piro F
    Minerva Urol Nefrol; 1998 Mar; 50(1):97-100. PubMed ID: 9578667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults.
    Antonen JA; Pyhälä R; Hannula PM; Ala-Houhala IO; Santanen R; Ikonen N; Saha HH
    Nephrol Dial Transplant; 2003 Apr; 18(4):777-81. PubMed ID: 12637648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Manenti A; Tete SM; Mohn KG; Jul-Larsen Å; Gianchecchi E; Montomoli E; Brokstad KA; Cox RJ
    Vaccine; 2017 Jan; 35(1):191-198. PubMed ID: 27789145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination.
    Noble GR; Kaye HS; O'Brien RJ; Kendal AP; Bregman DJ; Wright PF; Amler RW; Dowdle WR
    Dev Biol Stand; 1977 Jun 1-3; 39():253-60. PubMed ID: 604107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination in chronic hemodialysis patients. The effect of zinc supplementation.
    Grekas D; Alivanis P; Kotzadamis N; Kiriazopoulou V; Pyrpasopoulos M; Tourkantonis A
    Ren Fail; 1992; 14(4):575-8. PubMed ID: 1462010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to inactivated influenza vaccines of various antigenic concentrations.
    Sullivan KM; Monto AS; Foster DA
    J Infect Dis; 1990 Feb; 161(2):333-5. PubMed ID: 2299213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
    J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
    Ohmit SE; Petrie JG; Cross RT; Johnson E; Monto AS
    J Infect Dis; 2011 Dec; 204(12):1879-85. PubMed ID: 21998477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.